Experts respond to PLoS editorial comparing Chagas disease to HIV/AIDS

NewsGuard 100/100 Score

"Chagas disease, a parasitic infection spread to humans by insects, is not the new HIV/AIDS of the Americas, according to infectious disease experts who called the comparison," made in an editorial published in PLoS Neglected Tropical Diseases last week, "'unrealistic' and 'unfortunate,'" ABC News' "Medical Unit" blog reports. "Rick Tarleton, president of the Chagas Disease Foundation, said the diseases have little in common beyond disproportionately affecting poor people," the blog notes (Moisse, 6/1).

According to U.S. News & World Report, "the editorial's author [Peter Hotez, founding editor of PLoS Neglected Tropical Disease], says he wrote the essay to cause a stir." "I wrote it purposefully to have a provocative title. ... I didn't write this in any way to diminish the importance of HIV/AIDS," says Hotez, the news service writes (Koebler, 6/1). "'It's difficult to say whether the type of attention this is generating is going to be good or bad for people with the disease,' said Tarleton, describing how many people with Chagas disease face obstacles in getting care," the ABC News blog adds (6/1).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New drug candidates show promise to reverse HIV immune evasion